# Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection

> **NCT04290858** · PHASE2 · WITHDRAWN · sponsor: **Xijing Hospital**

## Conditions studied

- Coronavirus Infections
- Pneumonia, Viral
- Dyspnea

## Interventions

- **DRUG:** Nitric Oxide

## Key facts

- **NCT ID:** NCT04290858
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-03-01
- **Primary completion:** 2021-03-01
- **Final completion:** 2022-02-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** New coordinating center has been defined (Massachusetts General Hospital)
- **Last updated:** 2020-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04290858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04290858, "Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04290858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*